Authors:
Kristoferitsch, W
Seeldrayers, P
Kyriallis, K
Brochet, B
Confavreux, C
Clanet, M
Cesaro, P
Defer, G
Edan, G
Lyon-Caen, O
Pelletier, J
Rumbach, L
Roullet, E
Vermersch, P
Dengler, R
Zschenderlein, R
Storch-Hagenlocher, B
Sailer, M
Hohlfeld, R
Kunze, KP
Heesen, C
Bamborschke, P
Grunwald, F
Hartung, HP
Rieckmann, P
DeKeyser, J
Montalban, X
Fernandez, U
Arbizu, T
Sandberg, M
Kappos, L
Bates, D
Campbell, MJ
Capildeo, R
Compston, A
McLellan, DL
Wroe, S
Young, C
Clanet, M
Hartung, HP
Hohlfeld, R
Kappos, L
Radue, EW
Rieckmann, P
Sandberg, M
Polman, C
Kesselring, J
Thompson, A
Wekerle, H
Whitehead, J
Bains, H
Butler, E
Kooijmans-Coutinho, M
McAllister, A
Simonian, N
White, K
Anderson, D
Liddiard, S
Keane, R
Citation: W. Kristoferitsch et al., Double-blind randomized multicenter dose-comparison study of interferon-beta-1a (AVONEX): rationale, design and baseline data, MULT SCLER, 7(3), 2001, pp. 179-183
Authors:
Aktas, O
Waiczies, S
Grieger, U
Wendling, U
Zschenderlein, R
Zipp, F
Citation: O. Aktas et al., Polyspecific immunoglobulins (IVIg) suppress proliferation of human (auto)antigen-specific T cells without inducing apoptosis, J NEUROIMM, 114(1-2), 2001, pp. 160-167
Authors:
Lunemann, JD
Zarmas, S
Priem, S
Franz, J
Zschenderlein, R
Aberer, E
Klein, R
Schouls, L
Burmester, GR
Krause, A
Citation: Jd. Lunemann et al., Rapid typing of Borrelia burgdorferi sensu lato species in specimens from patients with different manifestations of lyme borreliosis (vol 39, pg 1130, 2001), J CLIN MICR, 39(5), 2001, pp. 2041-2041
Authors:
Lunemann, JD
Zarmas, S
Priem, S
Franz, J
Zschenderlein, R
Aberer, E
Klein, R
Schouls, L
Burmester, GR
Krause, A
Citation: Jd. Lunemann et al., Rapid typing of Borrelia burgdorferi sensu lato species in specimens from patients with different manifestations of Lyme borreliosis, J CLIN MICR, 39(3), 2001, pp. 1130-1133
Authors:
Lunemann, JD
Aktas, O
Gniadek, P
Zschenderlein, R
Zipp, F
Citation: Jd. Lunemann et al., Downregulation of transforming growth factor-beta 1 in interferon-beta 1a-treated MS patients, NEUROLOGY, 57(6), 2001, pp. 1132-1134
Authors:
Buttner, U
Chofflon, M
Hess, K
Kappos, L
Kesselring, J
Ludin, HP
Schluep, M
Vaney, C
Baumhackl, U
Berger, T
Deisenhammer, F
Freimuller, M
Hartung, HP
Kollegger, H
Kristoferitsch, W
Lassmann, H
Markut, H
Vass, K
Altenkirch, H
Boese, J
Gass, A
Gehlen, W
Goebels, N
Haas, J
Haferkamp, G
Heidenreich, F
Heitmann, R
Hemmer, B
Hohlfeld, R
Janzen, RWC
Jugelt, E
Kolmel, W
Konig, N
Kowitzsch, K
Manegold, U
Melms, A
Mertin, J
Petereit, HF
Pette, M
Pohlau, D
Poser, S
Sailer, M
Schmidt, S
Schock, G
Schulz, M
Seidel, D
Stangel, M
Stark, E
Stoll, G
Weinrich, W
Wietholter, H
Zettl, UK
Zipp, F
Zschenderlein, R
Bayas, A
Chan, A
Flachenecker, P
Gold, R
Grauer, O
Jung, S
Kallmann, B
Leussink, V
Maurer, M
Rieckmann, P
Toyka, KV
Weilbach, FX
Citation: U. Buttner et al., Escalating immunomodulatory therapy of multiple sclerosis - 1. Supplement, NERVENARZT, 72(2), 2001, pp. 150-157
Authors:
Holtkamp, M
Zschenderlein, R
Bruck, W
Weber, JR
Citation: M. Holtkamp et al., Chronic inflammatory demyelinating polyradiculoneuropathy with histologically proven optic neuritis, ACT NEUROP, 101(5), 2001, pp. 529-531
Authors:
Wendling, U
Aktas, O
Schmierer, K
Zschenderlein, R
Zipp, F
Citation: U. Wendling et al., Partial synergy of bisindolylmaleimide with apoptotic stimulus in antigen-specific T cells - implications for multiple sclerosis, J NEUROIMM, 103(1), 2000, pp. 69-75
Authors:
Aktas, O
Wendling, U
Zschenderlein, R
Zipp, F
Citation: O. Aktas et al., Apoptosis in multiple sclerosis - etiopathogenetic relevance and perspectives for new therapeutic strategies, NERVENARZT, 71(10), 2000, pp. 767-773
Authors:
Knirsch, UI
Bachus, R
Gosztonyi, G
Zschenderlein, R
Ludolph, AC
Citation: Ui. Knirsch et al., Clinicopathological study of atypical motor neuron disease with vertical gaze palsy and ballism, ACT NEUROP, 100(3), 2000, pp. 342-346
Authors:
Buttner, U
Chofflon, M
Hess, K
Kappos, L
Kesselring, J
Ludin, H
Rihs, F
Schluep, M
Vaney, C
Baumhackl, U
Berger, T
Freimuller, O
Hartung, HP
Kollegger, W
Kristoferitsch, W
Vass, K
Lassmann, H
Markut, S
Altenkirch, H
Boese, J
Gehlen, W
Goebels, N
Gold, R
Haas, J
Haferkamp, G
Heidenreic, F
Heitmann, R
Hohlfeld, R
Jugelt, E
Kolmel, H
Konig, N
Lowitzsch, K
Manegold, U
Mertin, J
Pette, M
Poser, S
Sailer, J
Schack, G
Schulz, M
Seidel, D
Stark, E
Stoll, G
Weinrich, W
Wietholter, H
Zettl, U
Zipp, F
Zschenderlein, R
Rieckmann, P
Toyka, KV
Chan, A
Bayas, A
Maurer, M
Jung, S
Gold, R
Weilbach, F
Cursiefen, S
Flachenecker, P
Rieckmann, P
Citation: U. Buttner et al., Escalating immunomodulatory therapy of multiple sclerosis, NERVENARZT, 70(4), 1999, pp. 371-386